CT 5002 An Open-Label, Non-Randomized, Monocentric Phase I Study Evaluating the Pharmacokinetic Profile of RhuDex [AV-1142742] Using a Tablet Formulation.

Trial Profile

CT 5002 An Open-Label, Non-Randomized, Monocentric Phase I Study Evaluating the Pharmacokinetic Profile of RhuDex [AV-1142742] Using a Tablet Formulation.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 26 Mar 2010

At a glance

  • Drugs AV 1142742 (Primary) ; Pantoprazole
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Mar 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 19 Oct 2009 Status changed from suspended to recruiting, as reported in a MediGene media release.
    • 14 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top